XML 69 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Parent Company Only Condensed Financial Information (Tables)
12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
Schedule of Balance Sheets

Balance Sheets

 

 

December 31,

 

 

2024

 

 

2023

 

(In thousands)

 

 

 

 

 

ASSETS

 

 

 

 

 

Noninterest-bearing cash equivalents

$

376

 

 

$

12,547

 

Investment in subsidiaries

 

334,381

 

 

 

309,015

 

Other Assets

 

8,197

 

 

 

7,075

 

TOTAL ASSETS

$

342,954

 

 

$

328,637

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

Subordinated debt

$

61,984

 

 

$

61,444

 

Other liabilities

 

749

 

 

 

1,397

 

Shareholders' equity

 

280,221

 

 

 

265,796

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$

342,954

 

 

$

328,637

 

Schedule of Condensed Statements of Operations and Comprehensive Income

Condensed Statements of Operations and Comprehensive Income

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

(in thousands)

 

 

 

 

 

 

Income:

 

 

 

 

 

 

Interest income

 

$

 

 

$

 

Dividend income from subsidiaries

 

 

3,900

 

 

 

 

Other income

 

 

86

 

 

 

 

Expenses:

 

 

 

 

 

 

Interest expense

 

 

3,869

 

 

 

1,926

 

Other noninterest expenses

 

 

1,245

 

 

 

5,135

 

Income before income tax

 

 

(1,128

)

 

 

(7,061

)

Income tax benefit

 

 

(1,056

)

 

 

(1,128

)

 

 

 

(72

)

 

 

(5,933

)

Equity in undistributed subsidiary (loss) income

 

 

26,281

 

 

 

(6,035

)

Net income (loss)

 

$

26,209

 

 

$

(11,968

)

Comprehensive income (loss)

 

$

24,873

 

 

$

(8,772

)

Schedule of Condensed Statements of Cash Flows

Condensed Statements of Cash Flows

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

(in thousands)

 

 

 

 

 

 

OPERATING ACTIVITIES

 

 

 

 

 

 

Net income (loss)

 

$

26,209

 

 

$

(11,968

)

Adjustments:

 

 

 

 

 

 

Undistributed (loss) earnings of subsidiaries

 

 

(30,181

)

 

 

6,035

 

Accretion (amortization) of premiums and discounts

 

 

540

 

 

 

(118

)

Share-based and deferred compensation

 

 

85

 

 

 

 

Other, net

 

 

(1,786

)

 

 

(549

)

Net cash used in operating activities

 

 

(5,133

)

 

 

(6,600

)

 

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

 

 

Net cash acquired through merger and acquisition

 

 

 

 

 

8,014

 

Investments in subsidiaries

 

 

 

 

 

(10,400

)

Cash dividends from subsidiaries

 

 

3,900

 

 

 

 

Net cash from dissolution of subsidiary

 

 

 

 

 

635

 

Net cash used in investing activities

 

 

3,900

 

 

 

(1,751

)

 

 

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

 

 

Proceeds from issuance of common stock, net

 

 

153

 

 

 

10,132

 

Issuance of shares from exercise of stock options

 

 

14

 

 

 

150

 

Dividends paid

 

 

(11,105

)

 

 

(4,870

)

Net cash provided by financing activities

 

 

(10,938

)

 

 

5,412

 

(Decrease) Increase in cash and cash equivalents

 

 

(12,171

)

 

 

(2,939

)

Cash and cash equivalents at the beginning of the period

 

 

12,547

 

 

 

15,486

 

Cash and cash equivalents at the end of the period

 

$

376

 

 

$

12,547